Concord Medical Co Ltd

Concord Medical Co Ltd

TTPEX:6518
29.65
TWD
+0.45
(+1.54%)
1.05BMarket Cap

Total Valuation

TWD

As of June 30, 2026, Concord Medical Co Ltd carries a market capitalization of 1.05B, placing it among publicly traded companies globally. Its enterprise value stands at 1.04B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.05B
Enterprise Value1.04B

Share Statistics

As of June 30, 2026, Concord Medical Co Ltd has 33.33M shares outstanding.

Shares Outstanding33.33M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio1.45
P/TBV Ratio1.49

Financial Position

As of June 30, 2026, Concord Medical Co Ltd maintains a current ratio of 1.66, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.

Current Ratio1.66
Quick Ratio0.67
Debt / Equity25.18

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count50.00

Stock Price Statistics

TWD

As of the close on November 17, 2026, Concord Medical Co Ltd's stock has gained approximately 14.04% over the past 52 weeks. The 50-day moving average sits at 31.22, while the 200-day moving average is 29.84.

52-Week Price Change14.04%
50-Day Moving Average31.22
200-Day Moving Average29.84

Balance Sheet

TWD

As of June 30, 2026, Concord Medical Co Ltd holds 225.93M in cash and equivalents against 189.28M in total debt, resulting in a net debt position of -92.99M. Total book value stands at 725.33M, with working capital of 222.52M providing operational flexibility.

Cash & Cash Equivalents225.93M
Total Debt189.28M
Net Debt-92.99M
Equity (Book Value)725.33M
Book Value Per Share21.76
Working Capital222.52M